DECN Archives - Page 3 of 4 - Blue Horseshoe Stocks

Fresh Ideas, Form-4 Alert

EFX Options Review

Despite a poor day for the market yesterday on the heels of oil futures falling to negative values, one of our daily trading ideas still produced for us fairly well. We had signaled EFX Weekly $126-129 Calls in yesterday’s premarket report, and half of that range saw incredible multibag gains.

While the $126-127’s were pushed a little too deep in the money, the $128-129’s absolutely exploded, with a nine and a four-bagger, respectively!

EFX Weekly $128-129 Calls
$284:.60-6.40 (+967%)
$285: 1.00-5.80 (+480%)

Fresh Options Ideas

We’ve got a few more ideas to add to our running watchlist this morning, with a heavy slate of earnings reporters catching our eye here in the premarket.

SNAP Weekly $14-15 Calls
CMG Weekly $810-840 Calls
BIIB Weekly $312-309 Puts

Siebert Financial Corp. SIEB – Form-4 Alert

We always try to keep an eye out for bottom plays with recent insider buying, and today it was SIEB that caught our attention. A member of a >10% Ownership Group purchased over $12M in SIEB at 5.80, just a bit higher than the stock’s recent annual lows.

Accordingly, we are going to place SIEB on our list of interesting stocks to track, and monitor its movements moving forward.

Extended Watchlist:
GRTD, CELZ, DECN, INVU

Incredible Options Trading Week!

Another Big Options Trading Week
–
UnitedHealth Group, Inc. UNH – We were just reporting on the solid gains made by our UNH idea yesterday, the UNH Weekly $270-277.50 Calls. It was a see-saw kind of a day for the markets at large, but there was still plenty of opportunity for us to increase our observed ranges on these plays since we began tracking them Wednesday morning:

UNH Weekly $270-277.50 Calls
$270: 6.00-26.50 (+342%)
$272.50: 4.21-26.00 (+518%)
$275: 3.30-20.00 (+506%)
$277.50: 2.39-21.40 (+795%)

_____

Johnson & Johnson JNJ – We’ve also been following the JNJ 09/18 $150-155 Calls since last Tuesday morning, and like the play above, are returning for the second straight day to highlight the impressive gains we’ve witnessed thus far:

JNJ 09/18 $150-155 Calls
$150: 2.90-10.17 (+251%)
$155: 2.27-7.50 (+230%)
____

The success with our options calls just kept coming this week, and that includes a pair of our ideas that were fresh for yesterday morning. We signaled interest in calls in the ABT and TSM chains, and saw some really nice moves there as well.

ABT Weekly $90-92.50 Calls
$90: 2.00-7.10 (+255%)
$92.50: .85-5.00 (+488%)
_____

TSM Weekly $50-52 Calls
$50: 1.86-3.16 (+70%)
$50.50:1.55-2.50 (+61%)
$51: 1.30-2.15 (+65%)
$51.50: .57-1.70 (+198%)
$52: .65-1.26 (+94%)

_____

More Fresh Ideas:
STT Weekly $60-65 Calls*
KSU Weekly $136-140 Calls*

*Never trade options with a weekly expiration on Friday unless you’re an expert level trader with access to disposable funds!

Moderna Inc. MRNA

We began tracking MRNA at the end of February, initially tagging the stock on February 27th and then again on March 16th. After seeing a low of 19.31 following that report, MRNA has been making steady headway in its run up the chart which has persisted for more than a month now.

Yesterday we saw a new recorded high of 41.55, which represents an overall increase of 115% since we began following the activity in MRNA.

Extended Watchlist:
CBDL, TURV, CNBX, DECN, GLGI, PWRMF, SBES, PCTL

DECN Recap & More

Decision Diagnostics, Corp. DECN

We began tracking DECN just under three weeks ago, back on the morning of March 19th. The stock caught our attention after announcing that it was working on a rapid-result COVID-19 test. Subsequent to that point in time, it was trading for as little as .056/share.

Yesterday, following another tag in our extended watchlist, and as an update on the company’s coronavirus test was provided (excerpt and link below), the stock reached some very impressive new highs. It’s not the first coronavirus related play we’ve scored on, and it won’t be the last.

DECN ran 216% intraday from .125 to a new high of .395. From our initially observed low from the week before last, the stock has now exhibited an upswing of 605%

Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc. …announces today that the company has received the Pre-EUA Acknowledgement letter from the U.S. FDA for device (serial number) PEUA200232, GenViro Covid-19 Screening Kit. This grant by the FDA is a major milestone in our GenViro!™ Covid-19 test kit development (>>View Full PR)

Johnson & Johnson JNJ – Recap

After seeing success with a number of different targets within the JNJ chain over the past week and change, we rolled our potential strike prices up to the JNJ Weekly $140-142 Calls yesterday morning.

Being one of the lead candidates for potentially developing an effective COVID-19 vaccine, it puts JNJ in a somewhat unique position, as experts have repeatedly stated that the world cannot begin to fully recover until a viable vaccine is being widely administered sometime next year.

Our move to the $140-142 Calls proved prudent yesterday, as early activity provided the following intraday opportunities:

JNJ Weekly $140-142 Calls
$140: .89-2.88 (+224%)
$141: .62-2.31 (+273%)
$142: .43-1.67 (+288%)
_____

Fresh Ideas:
LEVI 04/17 $12-13 Calls
SGH 04/17 $22.50-25 Calls

Extended Watchlist:
BIEI, MBRX PINS, BNGO, SONN, EFC, NYMT

Options Updates, Fresh Ideas

Options Updates
.
Johnson & Johnson JNJ – We initially made the longer-term call on the JNJ 09/18 $150-155 Calls at the beginning of last week, and yesterday morning as part of an update on those targets we also gave a more immediate idea with the JNJ Weekly $134-137 Calls. The markets absolutely ripped yesterday, and that catapulted both sets of ideas to new heights.

Here are the updated highs on last Monday’s September calls, as well as the single-session ranges on the weeklies:

09/18 $150-155 Calls
$150: 2.90-5.80 (+100%)
$155: 2.27-4.00 (+76%)

JNJ Weekly $134-137 Calls.
$134: 3.19-7.20 (+126%)
$135: 2.54-6.00 (+136%)
$136: 2.09-3.95 (+89%)

We would also like to roll up to include the Weekly $140-142 Calls on our watchlist.

______

SPDR S&P500 (ETF) SPY – We also signaled interest in a range of SPY calls in yesterday morning’s ;premarket report, highlighting the Weekly $258-260 Calls.

The bullish day for stocks across the board facilitated some very good moves in those three contract sets on the session. We expect these gains to be extended at the open, as the markets are gapping up once again this morning in early trading.

Weekly $258-260 Calls
$258: 4.07-10.66 (+162%)
$259: 3.61-9.98 (+176%)
$260: 3.11-9.25 (+197%)

Extended Watchlist:
CRON, TLRY, CGC, GUSH, BSGM, ALTD, HALB, DECN, NSPX, OZSC,

APRN Blows its Lid & More

Blue Apron Holdings Inc. APRN

We provided readers with a set of stocks that we felt were uniquely built to weather the coronavirus storm in yesterday morning’s premarket report. APRN had already begun to rise a little bit prior to that, but yesterday’s huge session really sent it for a ride.

The stock registered as the number three top gainer on the NASDAQ for its performance, which saw it trade up from a low 8.70 and hit 19.49, which represents an intraday rise of 124%. As of this morning’s premarket trading, APRN has now hit 24.50, extending our total observed range in 24 hours to 182%

With people being urged to stay home as much as possible, and perhaps with a mandatory nationwide quarantine on the way, we would expect Blue Apron’s order volume to stay at what we can only imagine are all time highs. As far as how high the stock could run, that’s anyone’s guess, but we’ll be tracking it closely to find out.

Decision Diagnostics Corp. DECN

Certain stocks on the OTC have also been enjoying solid performances in relation to the coronavirus. The company believes that its GenViro! COVID-19 “Rapid” Kit will be in high demand after the release of new FDA guidance allowing for near immediate distribution of kits with minimal red tape.

We had placed the stock in our extended watchlist in yesterday morning’s report, and were met with a very respectable intraday move from .118-.198, which works out to a gain of 68%

Fresh Options Ideas

GILD Weekly $79-81 Calls
WBA Weekly $52.50-54 Calls
HAL 04/03 $4-5.00 Calls